We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.61% | 3.05 | 3.00 | 3.10 | 3.15 | 3.05 | 3.10 | 1,785,708 | 13:41:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.16 | 2.75M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/12/2021 15:26 | Yep, as said before, the vultures have taken their pickings and left the rest high and dry. Might get a few more at 20-25p if some other dogs ever have their day. | daveboy19 | |
07/12/2021 12:24 | The val pump is over | jaforsadi | |
01/12/2021 11:22 | https://www.valirx.c | wulber | |
30/11/2021 13:04 | not this time, not this time. | 412069 | |
30/11/2021 12:53 | Fair enough, but its a helter skelter share and board. | daveboy19 | |
30/11/2021 12:30 | were all still here davey boy but just not posting. way oversold this is and the dry powders starting to come out. | 412069 | |
30/11/2021 11:09 | A familiar tale. Pumped and milked by the bigger vultures, and then off on their merry travels. | daveboy19 | |
30/11/2021 10:43 | All trading elsewhere | arab3 | |
30/11/2021 10:31 | Why's everyone abandoned this board.. it was ok tbh | reidy66 | |
30/11/2021 09:35 | Nico I am off Twitter now mate only in the telegram board if you ever want me. | 412069 | |
29/11/2021 12:15 | very quite on here this morn | humphries1 | |
25/11/2021 16:18 | Bullish : no raise needed for a long time Could be 4 uni tie ups a year Bearish :Mark and Kevin looked miserable : (Cenkos still haven't made one institutional buyer so we got diluted by 7pct for no reason.They preferred 201 deal with a smaller but I get impression we didn't have much choice ..just my gut feeling.All in all a neutral zoom meeting | nico115 | |
25/11/2021 15:41 | Nothing new in todays R & Q & it was reiterated that no fund raise required currently or expected in the near future .We are reviewing a very large number of pre clinical ,typically University originated, schemes & still hope to take on 4 projects pa,(primarily still in areas affecting womens health)which Suzy confirmed had not yet happened this year....but watch this space. One interesting snippet,which may have been mentioned previously but I am unaware of it , was the reference to the possibility of a treatment for Sepsis.Many have failed in the pursuit of Sepsis remedies & vast amounts have been invested by major drug companies in pursuing that holy grail without success-so far.Clearly we are unlikely to produce a drug which resolves Sepsis , but , as with Endometriosis, there is a massive unmet need & whichever organisation resolves these 2 issues will generate very substantial revenues.Pity no one asked how our Japanese colleagues are progressing. | base7 | |
25/11/2021 13:36 | Please see rns. Are my quotes from the rns accurate? Please investigate for yourself as this is factual financial details quoted! | jasonpugh | |
25/11/2021 12:51 | Jason, you have changed your tune on VAL from bullish to one of trying instil nervousness.Why the change of heart? The company is making all the right moves and reached dramatic inflection points such as cash rich, commercialised its first legacy IP, new investment strategy and broker and a solid BoD, plus a 7200% growth in share price from the George and Mildred days! | wulber | |
25/11/2021 06:30 | Obviously no information from the live Q and A can contain price sensitive rns info. However as it is only a letter of intent And none binding could it be that if the private company is unable to produce required equity have valirx lined up a possible replacement? Otherwise a definite cash raise from March onwards would be required based on cash burn projections from Valirx accounts rns (not cenkos evaluation). Just over £350k cash burn per quarter from Valirx accounts (rns from 27th April 2021 full year results). | jasonpugh | |
24/11/2021 07:58 | Feels like this may have some wind behind it. Could break 40p today if yesterday’s momentum maintained | francoismyname | |
23/11/2021 15:11 | A 1 trade is that news tomoz | humphries1 | |
23/11/2021 12:20 | I've watched it come and go 3 times, so anybody's guess. Took my stake out last time, so this is a free ride. Not as much reward, but this reflects my confidence in the Company at this moment. GLA. | daveboy19 | |
23/11/2021 11:13 | I think that will depend on the q&as If positive, which I'm confident it will be then it will hopefully be heading back into the 40s | cparry1989 | |
23/11/2021 11:02 | Even if it does, it will come back down - rinse and repeat. | daveboy19 | |
23/11/2021 10:57 | Would be Nice to see this break past 35p ready for the live q&as | cparry1989 | |
23/11/2021 08:00 | write up on armchair trader any one knows what it says ? | goldie40 | |
22/11/2021 15:35 | Starting to perk up & looking strong | wapper |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions